DXEVO Trademark

Trademark Overview

On Monday, March 11, 2019, a trademark application was filed for DXEVO with the United States Patent and Trademark Office. The USPTO has given the DXEVO trademark a serial number of 88334412. The federal status of this trademark filing is REGISTERED as of Tuesday, September 22, 2020. This trademark is owned by LARKEN LABORATORIES, INC.. The DXEVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating inflammation of the skin, joints, lungs, and other organs
dxevo

General Information

Serial Number88334412
Word MarkDXEVO
Filing DateMonday, March 11, 2019
Status700 - REGISTERED
Status DateTuesday, September 22, 2020
Registration Number6159110
Registration DateTuesday, September 22, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating inflammation of the skin, joints, lungs, and other organs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 13, 2020
Primary Code005
First Use Anywhere DateMonday, January 13, 2020
First Use In Commerce DateMonday, January 13, 2020

Trademark Owner History

Party NameLARKEN LABORATORIES, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCanton, MS 39046
Party NameLARKEN LABORATORIES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCanton, MS 39046
Party NameLARKEN LABORATORIES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCanton, MS 39046

Trademark Events

Event DateEvent Description
Monday, May 20, 2019NON-FINAL ACTION E-MAILED
Thursday, March 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 20, 2019ASSIGNED TO EXAMINER
Monday, May 20, 2019NON-FINAL ACTION WRITTEN
Monday, May 20, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 20, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 20, 2019NON-FINAL ACTION WRITTEN
Monday, May 20, 2019NON-FINAL ACTION E-MAILED
Monday, December 2, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, December 2, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, December 16, 2019TEAS PETITION TO REVIVE RECEIVED
Monday, December 16, 2019PETITION TO REVIVE-GRANTED
Monday, December 16, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 16, 2019NOTICE OF REVIVAL - E-MAILED
Monday, January 6, 2020ASSIGNED TO LIE
Monday, January 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 14, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 18, 2020PUBLISHED FOR OPPOSITION
Tuesday, January 14, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, January 14, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 14, 2020EXAMINER'S AMENDMENT ENTERED
Friday, July 24, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 17, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 18, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 22, 2020REGISTERED-PRINCIPAL REGISTER
Monday, September 22, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 24, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 7, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, July 7, 2020USE AMENDMENT FILED

Related Keywords

dxevo lungs other organs joints skin preparations treating inflammation pharmaceutical